(Q73686704)
Statements
Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers (English)
Joyce A O'Shaughnessy
Gary J Kelloff
Gary B Gordon
Ernest T Hawk
Caroline C Sigman